CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies...
Newly formed company raises US$2.3 million seed financing led by HeungKong Group to complete validation studies of optimized, humanized domain antibodies and explore broad applicability of DotBody technology